Instituto Pedro Nunes Leads the Next Steps of the VR Health Champions Project
General
Clique aqui para a versão em português.
Instituto Pedro Nunes participated in the second General Assembly of the VR Health Champions project, held on September 17th, in its role as Project Coordinator.
The meeting took place in Riga, Latvia, hosted by the University of Latvia, bringing together all partners to review progress, address key challenges, and define priorities for the next phase of the initiative.
The full-day meeting allowed each team to present what they have achieved so far, discuss the expected results, and analyse potential risks and ways to mitigate them. From coordination,user experience and testing, partners exchanged knowledge and strengthened the common action plan.
The assembly was also an opportunity to align on interregional challenges and ensure that the project continues to generate impact within the European health innovation ecosystem.
IPN continues to play a central role in coordination and technical support, ensuring that the solutions developed by the consortium are validated in real-world contexts.
Instituto Pedro Nunes participated in the second General Assembly of the VR Health Champions project, held on September 17th, in its role as Project Coordinator.
The meeting took place in Riga, Latvia, hosted by the University of Latvia, bringing together all partners to review progress, address key challenges, and define priorities for the next phase of the initiative.
The full-day meeting allowed each team to present what they have achieved so far, discuss the expected results, and analyse potential risks and ways to mitigate them. From coordination,user experience and testing, partners exchanged knowledge and strengthened the common action plan.
The assembly was also an opportunity to align on interregional challenges and ensure that the project continues to generate impact within the European health innovation ecosystem.
IPN continues to play a central role in coordination and technical support, ensuring that the solutions developed by the consortium are validated in real-world contexts.
